PROM1 and cancer: Interestingly, CD133 reportedly regulates the expression of NANOG and OCT4, suggesting that CD133 inhibition induces the GMI-mediated reduction in NANOG and OCT4.10 Regardless of the regulation on CD133, inhibition of NANOG and OCT4 suggested the potential of GMI in restraining cancer stem cells.